A Double-blind, Randomized and Controlled Multicenter Prospective Trial to Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2018
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 15 Jun 2018 Planned primary completion date changed from 1 Jan 2019 to 17 Apr 2019.
- 21 Aug 2017 Planned End Date changed from 30 Jun 2019 to 30 Aug 2019.
- 21 Aug 2017 Status changed from not yet recruiting to recruiting.